Evidence map›Paper›PMID 42149298›Full record

ReviewApoptosis : an international journal on programmed cell death2026

The IAP family member BRUCE/BIRC6: an emerging new player in balancing life and death.

Jiahui Dong, Xiufeng Xie, Yin Wang, Tianxia Jiang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiahui Dong *Ministry of Education Key Laboratory of Cell Proliferation and Regulation Biology, College of Life Sciences, Beijing Normal University, 19 Xinjiekouwai Avenue, Beijing, 100875, China.
Xiufeng Xie *Senior Department of Obstetrics and Gynecology, Chinese PLA General Hospital, No. 5 Nanmencang, Dongcheng District, Beijing, 100700, China.
Yin WangMinistry of Education Key Laboratory of Cell Proliferation and Regulation Biology, College of Life Sciences, Beijing Normal University, 19 Xinjiekouwai Avenue, Beijing, 100875, China.
Tianxia JiangMinistry of Education Key Laboratory of Cell Proliferation and Regulation Biology, College of Life Sciences, Beijing Normal University, 19 Xinjiekouwai Avenue, Beijing, 100875, China. jiangtx@bnu.edu.cn.

Funding

the National Key R & D Program of China 2023YFA1801902the Open Project Program of the State Key Laboratory of Medical Proteomics, the Chronic Disease Management Research Project of the National Health Commission Capacity Building and Continuing Education Center GWJJMB202510024224
6 · The paper itself

Abstract

Cell survival and death are the fundamental biological processes of life that involve both intracellular and extracellular dynamic events. How cells balance survival and death determines cell fate, and this question has attracted extensive research interest for decades yet remains largely unresolved. This review focuses on BRUCE, the only essential inhibitor-of-apoptosis (IAP) protein for survival. Based on recent structural discoveries regarding the autophagy-apoptosis switch, we provide novel mechanistic insights into this long-standing scientific question. BRUCE possesses a distinctive structure: its C-terminal UBC domain confers Ub conjugase (E2) and Ub-protein ligase (E3) activities, while its N-terminal region contains a baculoviral IAP repeat (BIR) domain. Benefiting from such distinctive structural properties. BRUCE centrally governs cell fate by modulating the transition from autophagy to apoptosis and maintaining genomic stability. At the organismal level, BRUCE sustains the homeostasis of reproductive and developmental processes by either inhibiting apoptosis or mediating substrate degradation. Aberrant BRUCE upregulation is widely implicated in diverse pathologies, including neurodevelopmental disorders and multiple malignancies. Nevertheless, research focusing on the targeted inhibition of BRUCE remains largely underexplored. A better understanding of the structural features and functional mechanisms of BRUCE will help elucidate how it exerts its pathogenic effects via regulation of cell survival and death. Such insights will lay a solid foundation for the future discovery and therapeutic application of specific BRUCE-targeted inhibitors. Outlooks and perspectives on the associated challenges are provided as well.

Indexed as

ApoptosisInhibitor of Apoptosis ProteinsAnimalsAutophagyCell SurvivalHumansBIRC6 protein, humanInhibitor of Apoptosis ProteinsApoptosisAutophagyBRUCE/BIRC6Cell survivalGenomic stabilityMalignant tumourNeurodevelopmental disorders

Identifiers

PMID42149298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.